Managing Thyroid Eye Disease: Rapid Response From ENDO

Overview

Provider Statement

This continuing education activity is provided by 

Support Statement

This activity is supported by an educational grant from Horizon Therapeutics USA, Inc.

Activity Description

For a timely diagnosis and optimal management of thyroid eye disease (TED), a multidisciplinary team of endocrinologists, ophthalmologists, oculoplastic surgeons, as well as other healthcare professionals is essential. Early diagnosis of TED through imaging and clinical assessment is imperative to allow for the timely initiation of therapeutic strategies that limit disfiguration and reduce the potential for vision loss. The recent updates to guidelines for the management of TED, along with the continued evaluation of therapeutics that address the underlying pathophysiology and course of disease, have resulted in a paradigm shift in the management of these patients. In this CE activity, a multidisciplinary team of experts evaluate new evidence and guidance pertaining to strategies that can improve the early diagnosis of TED and review the latest clinical evidence regarding the safety and efficacy of treatments for TED.

Target Audience

The intended audience for this activity is endocrinologists, ophthalmologists, and other health care professionals involved in the management of patients with thyroid eye disease (TED).

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

• Evaluate new evidence and guidance pertaining to strategies that can improve the early diagnosis of thyroid eye disease (TED).
• Review the most recent clinical evidence regarding the safety and efficacy of treatments for TED, as well as multidisciplinary approaches that can improve patient care.

Activity Chair

Terry J. Smith, MD
Frederick G.L. Huetwell Professor
Ophthalmology and Visual Sciences
Professor of Internal Medicine
University of Michigan Medical School
Ann Arbor, MI

Faculty

Eve Bloomgarden, MD
Director of Thyroid Care
Director of Endocrine Innovation and Education
Division of Endocrinology NorthShore University Health Systems
Chief Operating Officer, Co-Founder IMPACT
Chief Development Officer, Women in Medicine® NFP
Evanston, IL

Sara Tullis Wester, MD, FACS
Professor of Clinical Ophthalmology
Oculofacial Plastic and Reconstructive Surgery
Orbital Surgery and Oncology
Bascom Palmer Eye Institute
University of Miami Miller School of Medicine
Miami, FL

Planner/Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

Accreditation

In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, June 25, 2023, to June 24, 2024.

How to Participate in This Activity and Obtain CE Credit

To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 75% of the posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.

Disclosures

Vindico Medical Education adheres to the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Relationship information is accurate at the time of content development.

Activity Chair and Faculty report the following relevant financial relationship(s)

Eve Bloomgarden, MD
Speaker Contracted by Ineligible Company: Horizon

Terry J. Smith, MD
Royalties or Patent Beneficiary: Horizon
Advisor: Horizon
Consultant: Horizon, Viridian
Speaker Contracted by Ineligible Company: Horizon
Individual Stocks and Stock Options: Viridian

Sara Tullis Wester, MD, FACS
Advisor: Horizon
Consultant: Immunovant, Lassen Therapeutics, Sling
Independent Research Contractor: Horizon, Immunovant, Sling

Planner/Reviewer reports the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relevant financial relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2023 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CE Questions?

Contact us at cme@vindicoCME.com